89Zr-atezolizumab PET scans

OTHER2 trials

Sponsors

University Medical Center Groningen

Conditions

Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedLobular Metastatic Breast Cancer

Unknown Phase

Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients

WithdrawnNCT03850028

University Medical Center GroningenDiffuse Large B-Cell Lymphoma, Not Otherwise Specified

Start: 2019-05-22End: 2022-05-01Updated: 2023-05-15

89Zr-atezolizumab PET Scan and Lobular Breast Cancer

TerminatedNCT04222426

University Medical Center GroningenLobular Metastatic Breast Cancer

Start: 2019-12-18End: 2022-05-01Updated: 2022-07-01

Related Papers

PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial.

2023-04-1024 citations